After reducing their losses during the morning through the PMI Markit Eurozone, European stock dig again overtaken by a depressing environment for all global markets.
Athens abandons 2.6 %, Amsterdam and Zurich 2.2% 2.1% 1.6% loses London, Milan, Madrid and Lisbon 1.4%, Frankfurt, Paris and Brussels 1.1%. In New York, the Dow Jones and Nasdaq 0.9% each unleash yet
In the wake of the US indices yesterday. – Who had then suffered their worst session of the year – Tokyo lost nearly 3% late Friday session, while Shanghai still won by nearly 4.3%.
‘Global markets went into panic mode when the extent of China’s economic slowdown is beginning to be perceived without that investors have changed their forecast of an increase in the Fed’s September rate ‘, was explained this morning at IG.
The US economy has yet given a new sign of weakness that afternoon, with the Markit PMI which fell to 52.9 in flash estimate for August, its lowest level since October 2013.
‘The resignation of Alexis Tsipras, who hopes to see its legitimacy strengthened in the upcoming early elections in Greece on September 20, will also create a (small) political uncertainty in a context already anxiety ‘, also notes a manager of Barclays stock.
In a bleak context, markets do not benefit long the flash estimate of the Markit PMI for the euro area, which rose slightly to 54.1 this month, and therefore indicated an expansion continues to private sector activity in the region.
The data show a faster rise in overall activity in Germany and positive performances for France. Outside the Franco-German core, growth accelerated to its highest level since July 2007.
“These data underscore the ability of the eurozone to absorb the shock of the Greek crisis and it has created a stir last month ‘commented Rob Dobson, senior economist at Markit.
In terms of values, TNT Express manages to remain close to balance (-0.1% ) in Amsterdam, FedEx has announced the launch of a friendly takeover bid for the Dutch logistics group, valued at 4.4 billion euros.
Novartis was down 2.7% in Zurich, while the Swiss healthcare group will do the acquisition from GSK (-2% in London) of all rights Ofatumumab, an experimental treatment against multiple sclerosis and other autoimmune diseases.
A reverse trend, Mercialys signed the largest increase of the Paris SBF120 and garnered 3.3%, which is explained by the increase of recommendation from Goldman Sachs’ neutral “to” buy “on the title land.
Copyright (c) 2015 CercleFinance.com. All rights reserved.
No comments:
Post a Comment